Go through these in order and stop at the first one that applies. If you are reading this for someone else, answer for them.
And for anyone, someone who:
Between visits, promptly report fever, bleeding, unusual bruising, worsening fatigue, shortness of breath, or repeated infections.
Persistent sleep problems, poor appetite, anxiety, or difficulty returning to daily activities should also be discussed with the care team.
And for anyone, someone who:
Follow-up continues during treatment, after remission, and after transplant when applicable.
Visits usually include symptom review, physical examination, and blood counts.
Bone marrow testing may be repeated to assess response or investigate abnormal results.
Follow-up is generally more frequent soon after treatment and may become less frequent over time.
Care also addresses infection prevention, vaccines, nutrition, physical recovery, emotional health, fertility, and long-term treatment effects.
Stem cell transplant recipients require specialized monitoring for infection, graft-versus-host disease, and immune recovery.
The article also says
Some centers test for measurable residual disease, or MRD.
MRD means small numbers of leukemia cells remain even though standard tests suggest remission.
Results may help estimate relapse risk, but their meaning depends on the AML subtype, test method, and treatment stage.
Every sign above is quoted from the sofidex article on Acute myeloid leukemia - adult. If you are not sure, err upward — it is always reasonable to be checked.